369 related articles for article (PubMed ID: 31324257)
1. Statistical evaluation of worst-case robust optimization intensity-modulated proton therapy plans using an exhaustive sampling approach.
Yang Z; Li H; Li Y; Li Y; Chang Y; Li Q; Yang K; Wu G; Sahoo N; Poenisch F; Gillin M; Zhu XR; Zhang X
Radiat Oncol; 2019 Jul; 14(1):129. PubMed ID: 31324257
[TBL] [Abstract][Full Text] [Related]
2. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
3. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
[TBL] [Abstract][Full Text] [Related]
5. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
Bai X; Lim G; Grosshans D; Mohan R; Cao W
Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
[TBL] [Abstract][Full Text] [Related]
6. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
[TBL] [Abstract][Full Text] [Related]
7. Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers.
Yang Z; Zhang X; Wang X; Zhu XR; Gunn B; Frank SJ; Chang Y; Li Q; Yang K; Wu G; Liao L; Li Y; Chen M; Li H
Radiother Oncol; 2020 Jan; 142():124-132. PubMed ID: 31564553
[TBL] [Abstract][Full Text] [Related]
8. Robust optimization of intensity modulated proton therapy.
Liu W; Zhang X; Li Y; Mohan R
Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
[TBL] [Abstract][Full Text] [Related]
9. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
[TBL] [Abstract][Full Text] [Related]
10. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.
Liu W; Liao Z; Schild SE; Liu Z; Li H; Li Y; Park PC; Li X; Stoker J; Shen J; Keole S; Anand A; Fatyga M; Dong L; Sahoo N; Vora S; Wong W; Zhu XR; Bues M; Mohan R
Pract Radiat Oncol; 2015; 5(2):e77-86. PubMed ID: 25413400
[TBL] [Abstract][Full Text] [Related]
11. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
[TBL] [Abstract][Full Text] [Related]
12. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
13. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
[TBL] [Abstract][Full Text] [Related]
14. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
15. A fast robust optimizer for intensity modulated proton therapy using GPU.
Xu Y; Chen J; Cao R; Liu H; Xu XG; Pei X
J Appl Clin Med Phys; 2020 Mar; 21(3):123-133. PubMed ID: 32141699
[TBL] [Abstract][Full Text] [Related]
16. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
17. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma.
Feng H; Shan J; Ashman JB; Rule WG; Bhangoo RS; Yu NY; Chiang J; Fatyga M; Wong WW; Schild SE; Sio TT; Liu W
Med Phys; 2021 Aug; 48(8):4636-4647. PubMed ID: 34058026
[TBL] [Abstract][Full Text] [Related]
18. Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.
Huiskes M; Kong W; Oud M; Crama K; Rasch C; Breedveld S; Heijmen B; Astreinidou E
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):968-977. PubMed ID: 38284961
[TBL] [Abstract][Full Text] [Related]
19. Quantification of plan robustness against different uncertainty sources for classical and anatomical robust optimized treatment plans in head and neck cancer proton therapy.
Cubillos-Mesías M; Troost EGC; Lohaus F; Agolli L; Rehm M; Richter C; Stützer K
Br J Radiol; 2020 Mar; 93(1107):20190573. PubMed ID: 31778315
[TBL] [Abstract][Full Text] [Related]
20. Robust intensity-modulated proton therapy to reduce high linear energy transfer in organs at risk.
An Y; Shan J; Patel SH; Wong W; Schild SE; Ding X; Bues M; Liu W
Med Phys; 2017 Dec; 44(12):6138-6147. PubMed ID: 28976574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]